Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Boehringer Ingelheim
Harvard Business School
Medtronic
Express Scripts

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Litigation Details for ALLERGAN, INC. v. APOTEX INC. (M.D.N.C. 2010)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

ALLERGAN, INC. v. APOTEX INC. (M.D.N.C. 2010)

Docket   Start Trial Date Filed 2010-09-08
Court District Court, M.D. North Carolina Date Terminated 2013-01-25
Cause 15:1126 Patent Infringement Assigned To Catherine Caldwell Eagles
Jury Demand Both Referred To MAG/JUDGE L. PATRICK AULD
Parties ALLERGAN, INC.; APOTEX CORP.; APOTEX INC.; APOTEX, INC.; DUKE UNIVERSITY; SANDOZ, INC.
Patents 5,688,819; 6,403,649; 7,351,404; 7,388,029
Attorneys A. MARTINA HUFNAL; ANDREW M. ALUL; BRANDON C. HELMS; BRYAN G. SCOTT; CRAIG E. COUNTRYMAN; DARRELL A. FRUTH; DAVID MATTHEW WILKERSON; DEANNA J. REICHEL; DEANNE M. MAZZOCHI; DOUGLAS E. MCCANN; ERIC M. DAVID; F. HILL ALLEN , IV; HARVEN V. DESHIELD; HEINZ J. SALMEN; JEFFREY DEAN PATTON; JEFFREY T. THOMAS; JENNIFER HALL; JIM W. PHILLIPS , JR.; JONATHAN E. SINGER; JUANITA R. BROOKS; LIMIN ZHENG; LUKE T. SHANNON; MEREDITH MARTIN ADDY; NEIL A. BENCHELL; PAUL J. MOLINO; RANDAL S. ALEXANDER; TARA M. RAGHAVAN; THOMAS A. RAMMER; THOMAS J. FILARSKI; TIMOTHY F. PETERSON; WILLIAM A. RAKOCZY
Firms Brooks Pierce McLendon Humphrey & Leonard; Brooks Pierce McLendon Humphrey & Leonard, L.L.P.; Rakoczy Molino Mazzochi Siwik, LLP; Steptoe & Johnson LLP; Steptoe and Johnson LLP; Tharrington Smith, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in ALLERGAN, INC. v. APOTEX INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for ALLERGAN, INC. v. APOTEX INC. (M.D.N.C. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-09-08 1 Complaint States Patent Nos. 7,351,404 (“the ’404 patent”), 7,388,029 (“the ’029 patent”), and 6,403,649 (“the …1 Exhibit A - '404 Patent, # 2 Exhibit B - '029 Patent, # 3 Exhibit C - '649 Patent) (PATTON, JEFFREY)… Listed Patents are the ’404,’029, and ’649 patents. The FDA has published the Listed Patents in the …title, and interest in the ’404 patent. 25. The ’029 patent, entitled “Compositions and Methods…the ’029 patent. 27. Allergan is an exclusive field licensee of the ’029 patent. External link to document
2013-01-24 208 published Aug. 6, 1998). 5 U.S. Patent No. 5,688,819 (filed Nov. 18, 1997). …the ‘029 Patent, (PTX 2); and the ‘819 Patent, (DTX 717). The ‘819 Patent and the ‘029 Patent application…‘029 Patent is not a genus so small that it discloses the ‘404 Patent’s claims. The ‘029 Patent expressly…collectively “Plaintiffs”), and U.S. Patent No. 7,351,404 (“the ‘404 Patent”), which is owned by Allergan. … not infringe on Plaintiffs’ patents, and that if they do, the patents are invalid due to anticipation External link to document
2013-01-25 209 Judgment of 2 U.S. Patent No. 7,388,029 (“the ‘029 Patent”) and claim 14 of U.S. Patent No. 7,351,404 (“the ‘404…‘404 Patent”). It is further ORDERED AND ADJUDGED that Judgment is entered in favor of Plaintiffs…noninfringement or invalidity of the ‘029 and ‘404 Patents. It is further ORDERED that, pursuant to…dates of the ‘029 and ‘404 Patents; 2. the effective date of approval…later of the expiration dates of the ‘029 and ‘404 Patents; and 3. the effective date of External link to document
2013-04-23 231 Permanent Injunction expiration dates of U.S. Patent No. 7,351,404 and U.S. Patent No. 7,388,029. 2. Sandoz…the expiration dates of U.S. Patent No. 7,351,404 and U.S. Patent No. 7,388,029. 3. Hi-Tech…expiration dates of U.S. Patent No. 7,351,404 and U.S. Patent No. 7,388,029. This the 23rd day… 25 January 2013 1:10-cv-00681-CCE-LPA Patent Both District Court, M.D. North External link to document
2011-10-21 39 Stipulation Plaintiffs' Count III with Respect to U.S. Patent No. 6,403,649 by ALLERGAN, INC., DUKE UNIVERSITY. Associated… 25 January 2013 1:10-cv-00681-CCE-LPA Patent Both District Court, M.D. North External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Mallinckrodt
Merck
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.